retatrutide phase 3 triumph Looking forward to when #retatrutide's trial results will become available. There are are 4 planned trials investigating retatrutide's efficacy in treating obesity and its complications: #type2diabetes #cardiovascular disease Eli Lilly's New Weight-Loss Treatment

A new study muddles the picture.

This study included 41 participants (RYGB: n=21, OAGB: n=20) from the randomized RYSA trial with similar amounts of bypassed intestine between the procedures

Lillys tirzepatide has gained a strong reputation for efficacy in these markets, and while evidence is limited, in Indiavit has signalled that it will attempt to maintain premium pricing rather than compete against the off-patent offerings

New trials suggest GLP-1 therapies may improve osteoarthritis pain and mobility in patients with obesity

However, heterogeneity in weight loss response, cost, side effects, and need for injections may limit their use in many pediatric patients